Respiratory Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Non-Adherence to Asthma a Growing Problem

An analysis published in the Journal of Clinical Pharmacy and Therapeutics of asthma medication adherence showed poor coverage across a six-month period.

New Recs for IPF Rx Therapy

Updated guidelines on the treatment of idiopathic pulmonary fibrosis (IPF) by the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association have been published.

Cloud9 Anti-Snoring System Approved

The FDA has cleared its Cloud9 Anti-Snoring System to reduce or eliminate asymptomatic ("simple") snoring in adults.

When Should LABA Therapy Be Stopped?

An article highlights studies on cessation of LABA compared to continued use of LABA/ICS for adults with well-controlled asthma to determine whether stopping LABA treatment has an impact on asthma control, exacerbations, and other serious adverse events.

Soy Supplements for Uncontrolled Asthma

A new study has found that supplementation with soy isoflavone did not improve lung function or critical outcomes in patients with poor asthma control, despite previous research suggesting that it may be an effective treatment.

Regular Aspirin May Slow Emphysema Progression

Regular aspirin use is associated with a slower progression of early emphysema on computed tomography (CT) scans over the course of 10 years.

Breo Ellipta Inhaler Gains Expanded Indication

GlaxoSmithKline and Theravance announced that the Food and Drug Administration (FDA) has approved Breo Ellipta (fluticasone furoate/vilanterol) for the once-daily treatment of asthma in patients aged ≥18 years.

COPD and Sudden Cardiac Death Risk

Chronic obstructive pulmonary disease (COPD) is already the third leading cause of death in the world, and the condition might also raise a patient's odds for sudden cardiac death.


'GOLD' Criteria May Misdiagnosis Normal Phenotypes

Among adults with GLI-defined normal spirometry

Study: Many Stage IV NSCLC Patients Overtreated

Stage IV nonsmall-cell lung cancer (NSCLC) patients in the United States often receive more radiation therapy than recommended.

FDA Approves New Indication for Keytruda

The Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for Keytruda (pembrolizumab) for the treatment of metastatic non-small cell lung cancer (NSCLC) in patients whose disease has progressed after other treatments and with tumors that express PD-L1.

Study Raises Concerns Over Narcotic Use in Older COPD Patients

A new study is raising safety concerns about the high rate of new opioid use among older adults with chronic obstructive pulmonary disease (COPD).

Featured courses from mycme

Comprehensive Review of Family MedicineExternal web site

This comprehensive review covers the full spectrum of topics applicable to Family Medicine through lectures ...

CME 57.00 Credits

Reduced-Nicotine Cigarettes: Safer Than Conventional Products?External web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

ACP Guideline Calls for Smarter Testing in PE EvaluationExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters